Specific HIV-1 TAR RNA Loop Sequence and Functional Groups Are Required for Human Cyclin T1−Tat−TAR Ternary Complex Formation
The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Replication of human immunodeficiency virus requires Tat protein which activates elongation of RNA polymerase II transcription at the HIV-1 promoter through interaction with the cyclin T1 (CycT1) subunit of the positive transcription elongation factor complex (P-TEFb). Tat binds directly through its transactivation domain to the CycT1 subunit of the P-TEFb and induces loop sequence specific binding of the P-TEFb onto nascent HIV-1 TAR RNA. By using a gel electrophoresis method and a comprehensive set of TAR loop mutants, we have identified the sequence and structural determinants for high-affinity CycT1-Tat-TAR ternary complex formation. Our results show that CycT1 and Tat binding to TAR RNA is highly cooperative, and a capacity of 85%, a Hill coefficient of 2.7, and a dissociation constant (K(D)) of 2.45 nM were observed. These results indicate that there are three binding sites on TAR RNA. CycT1 does not bind TAR RNA in the absence of Tat, and Tat binding to TAR, while detectable, is very inefficient in the absence of CycT1. It is conceivable that the CycT1-Tat heterodimer directly binds to TAR RNA in the U-rich RNA bulge region and this binding facilitates the interactions of the CycT1-Tat heterodimer at the other two sites in the RNA loop region. On the basis of our results, we suggest a model where CycT1 interacts with Tat protein and positions the protein complex to make contacts with the G34 region of the loop sequence; G34 is critical for CycT1-Tat binding and forms a C30.G34 base pair. Two functional groups, O6 and N7, at nucleotide positions 32 and 34 in the TAR loop are essential for CycT1-Tat interactions with TAR RNA. The identity of two nucleotides, U31 and G33, is not critical, but they contribute to the stabilization of the RNA-protein complex. The presence of a single-nucleotide bulge of A35 or C35 is essential for distortion of the backbone RNA structure as well as the accessibility of functional groups in the major groove of the double-helical region. CycT1-Tat interaction with TAR RNA represents another example of the flexibility and complexity of RNA structure involved in protein recognition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The putative cleavage site was positioned at the neck of the stem loop region of TAR, which is critical for Cyclin T1-Tat-TAR ternary complex formation 19 .”
From Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus (2013) · cites this paper as [19]
Citations
Cites
Dingwall, C., Ernberg, I., Gait, M. J., Green, S. M., Heaphy, S., Karn, J., Lowe, A. D., Singh, M., & Skinner, M. A. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07637.x · Cited by 407
Cooperativity Theory in Biochemistry
Hill, T. L. (1985) · Springer eBooks · doi:10.1007/978-1-4612-5082-1 · Cited by 282
Garcia, J. A., Harrich, D., Soultanakis, E., Wu, F., Mitsuyasu, R., & Gaynor, R. B. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb03437.x · Cited by 280
Bieniasz, P. D., Grdina, T. A., Bogerd, H. P., & Cullen, B. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.7056 · Cited by 260
Berkhout, B., & Jeang, K. T. (1989) · Journal of Virology · doi:10.1128/jvi.63.12.5501-5504.1989 · Cited by 223
Biochemical and Functional Interactions between HIV-1 Tat Protein and TAR RNA
Rana, T. M., & Jeang, K.-T. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1206 · Cited by 173
Self-citationFujinaga, K., Cujec, T. P., Peng, J., Garriga, J., Price, D. H., Graña, X., & Peterlin, B. M. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7154-7159.1998 · Cited by 164
Isel, C., & Karn, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2933 · Cited by 131
Gold, M. O., Yang, X., Herrmann, C. H., & Rice, A. P. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4448-4453.1998 · Cited by 117
Cyclin T1 domains involved in complex formation with tat and TAR RNA are critical for tat-activation
Ivanov, D., Kwak, Y. T., Nee, E., Guo, J. Q., García-Martínez, L. F., & Gaynor, R. B. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.2663 · Cited by 85
Sumner-Smith, M., Roy, S., Barnett, R. W., et al. (1991) · Journal of Virology · doi:10.1128/jvi.65.10.5196-5202.1991 · Cited by 80
Bieniasz, P. D., Grdina, T. A., Bogerd, H. P., & Cullen, B. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.7.5777-5786.1999 · Cited by 39
Human Immunodeficiency Virus Type 2
Bektimirov, T. A. (1999) · Journal of the Association of Nurses in AIDS Care · doi:10.1016/s1055-3290(06)60236-7 · Cited by 16
Research works printed but not linked: 26
- Jones K. A., 1997, Genes Dev. 11, 2593−2599
- Cullen B. R., 1998, Cell 93, 685−692
- Emerman M., 1998, Science 280
- Jeang K.-T., 1999, J. Biol. Chem., 274
- Taube R., 1999, Virology 264, 245−253
- Zhu Y., 1997, Genes Dev. 11, 2622−2632
- Mancebo H. S. Y., 1997, Genes Dev. 11, 2633−2644
- Wei P., 1998, Cell 92, 451−462
- Garber M. E., 1998, Genes Dev. 12, 3512−3527
- Garber M. E., 1998, Cold Spring Harbor Symp. Quant. Biol. 63, 371−380
- Bieniasz P. D., 1999, Proc. Natl. Acad. Sci. U.S.A. 96, 7791−7796
- Wimmer J., 1999, Virology 255, 182−189
- Fujinaga K., 1999, Proc. Natl. Acad. Sci. U.S.A. 96, 1285−1290
- Chen D., 1999, Proc. Natl. Acad. Sci. U.S.A. 96, 2728−2733
- Rosen C. A., 1985, Cell 41, 813−823
- Jakobovits A., 1988, Mol. Cell. Biol. 8, 2555−2561
- Selby M. J., 1989, Genes Dev. 3, 547−558
- Muesing M. A., 1987, Cell 48, 691−701
- Berkhout B., 1989, Cell 59, 273−282
- Dingwall C., 1989, Proc. Natl. Acad. Sci. U.S.A. 86, 6925−6929
- Feng S., 1988, Nature 334, 165−167
- Cordingley M. G., 1990, Proc. Natl. Acad. Sci. U.S.A. 87, 8985−8989
- Milligan J. F., 1987, Nucleic Acids Res. 15, 8783−8798
- Wang Z., 1996, Biochemistry 35, 6491−6499
- Neenhold H. R., 1995, Biochemistry 34, 6303−6309
- Weeks K. M., 1993, Science 261, 1574−1577
Cited by
Targeting RNA with Small Molecules
Thomas, J. R., & Hergenrother, P. J. (2008) · Chemical Reviews · doi:10.1021/cr0681546 · Cited by 647
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Ebina, H., Misawa, N., Kanemura, Y., & Koyanagi, Y. (2013) · Scientific Reports · doi:10.1038/srep02510 · Cited by 565
Fujinaga, K., Luo, Z., & Peterlin, B. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.557751 · Cited by 20
Metadata
- Authors
- Richter, S., Cao, H., & Rana, T. M.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Rana, Tariq M.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2002-04-24
- Volume
- 41
- Issue
- 20
- Pages
- 6391-6397
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2088450977
- Cited by
- 76
- References
- 13
- Citations by year
- 2026: 1 · 2024: 2 · 2023: 2 · 2022: 1 · 2021: 1 · 2020: 1 · 2019: 3 · 2018: 5 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 4 · 2013: 1 · 2012: 4
- FWCI
- 2.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biochemistry (publishedVersion)
- PubMed (publishedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI043198, AI 41404)
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Keywords
- HIV-1 TAR RNA, cyclin T1, Tat protein, P-TEFb, ternary complex formation, RNA-protein interactions, RNA bulge, transactivation domain, RNA structure, transcription elongation, cooperative binding
- MeSH terms
- Base Sequence, Humans, Mutation, Nucleic Acid Conformation, Protein Binding, Purine Nucleotides, Pyrimidine Nucleotides, RNA, Viral, HIV-1, Gene Products, tat, Cyclins, HIV Long Terminal Repeat, Macromolecular Substances, tat Gene Products, Human Immunodeficiency Virus, Cyclin T
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.